285 related articles for article (PubMed ID: 31736241)
1. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.
Wang SC; Yang KD; Lin CY; Huang AY; Hsiao CC; Lin MT; Tsai YG
Pediatr Blood Cancer; 2020 Feb; 67(2):e28075. PubMed ID: 31736241
[TBL] [Abstract][Full Text] [Related]
2. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
[TBL] [Abstract][Full Text] [Related]
3. Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia.
Audia S; Moulinet T; Ciudad-Bonté M; Samson M; Facy O; Ortega-Deballon P; Saas P; Bonnotte B
J Autoimmun; 2018 Sep; 93():139-144. PubMed ID: 30055825
[TBL] [Abstract][Full Text] [Related]
4. Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
Fahim NM; Monir E
Egypt J Immunol; 2006; 13(1):173-87. PubMed ID: 17974160
[TBL] [Abstract][Full Text] [Related]
5. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients.
Li F; Ji L; Wang W; Hua F; Zhan Y; Zou S; Yuan L; Ke Y; Min Z; Song D; Sun L; Chen H; Cheng Y
Immunol Res; 2015 Mar; 61(3):269-80. PubMed ID: 25550089
[TBL] [Abstract][Full Text] [Related]
6. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
[TBL] [Abstract][Full Text] [Related]
7. The abnormal function of CD39
Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM
Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia.
Li Q; Liu Y; Wang X; Sun M; Wang L; Wang X; Liu Y; Fan W; Zhang K; Sui X; Guo X
Exp Biol Med (Maywood); 2021 Aug; 246(15):1688-1697. PubMed ID: 33938255
[TBL] [Abstract][Full Text] [Related]
10. The short-term predictive value of CD4
Liu H; Liu X; Zhang G; Wang J; Naren D; Xie S; Li Y; Nie D; Li Z; Ma L
Thromb Res; 2022 Oct; 218():157-168. PubMed ID: 36054980
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
12. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
[TBL] [Abstract][Full Text] [Related]
13. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Papagianni A; Economou M; Tragiannidis A; Karatza E; Tsatra I; Gombakis N; Athanassiadou-Piperopoulou F; Athanasiou-Metaxa M
J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
[TBL] [Abstract][Full Text] [Related]
14. The potential therapeutic benefit of resveratrol on Th17/Treg imbalance in immune thrombocytopenic purpura.
Guo NH; Fu X; Zi FM; Song Y; Wang S; Cheng J
Int Immunopharmacol; 2019 Aug; 73():181-192. PubMed ID: 31102993
[TBL] [Abstract][Full Text] [Related]
15. Transcription Factor IRF4 Dysfunction Affects the Immunosuppressive Function of Treg Cells in Patients with Primary Immune Thrombocytopenia.
Tang M; Cheng L; Li F; Wu B; Chen P; Zhan Y; Hua F; Min Z; Ke Y; Liu C; Yuan L; Sun L; Chen H; Ji L; Cheng Y
Biomed Res Int; 2019; 2019():1050285. PubMed ID: 31380412
[TBL] [Abstract][Full Text] [Related]
16. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
[TBL] [Abstract][Full Text] [Related]
17. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
[TBL] [Abstract][Full Text] [Related]
18. Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia.
Hao Y; Li H; Li Y; Lyu M; Zhang D; Fu R; Guan Y; Wang S; Sun B; Dou X; Yang R
Autoimmunity; 2017 Aug; 50(5):283-292. PubMed ID: 28412855
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
Hedlund-Treutiger I; Henter JI; Elinder G
J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.
Heitink-Pollé KMJ; Uiterwaal CSPM; Porcelijn L; Tamminga RYJ; Smiers FJ; van Woerden NL; Wesseling J; Vidarsson G; Laarhoven AG; de Haas M; Bruin MCA;
Blood; 2018 Aug; 132(9):883-891. PubMed ID: 29945954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
